Analyst Price Target is $19.50
▲ +23.50% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Sabra Health Care REIT in the last 3 months. The average price target is $19.50, with a high forecast of $21.00 and a low forecast of $17.00. The average price target represents a 23.50% upside from the last price of $15.79.
Current Consensus is
The current consensus among 5 investment analysts is to buy stock in Sabra Health Care REIT. This rating has held steady since February 2021, when it changed from a Hold consensus rating.